Viral Products
Accelerating Progress and Speed to Market
Integrated CDMO and Testing services for viral products used in the production of biopharmaceuticals are designed to expedite time to clinic and support commercial programs around the world. By leveraging over three decades of virology expertise, we offer the following:
-
Expedited tech transfer
-
FDA Registered facilities
-
Integrated manufacturing and testing including genetic sequencing, adventitious agent screening, and stability studies
-
Process and Analytical Development
-
Scalable capacity
-
Global regulatory support
Virus experience includes:
-
Lentivirus
-
Retrovirus
-
Adeno-Associated Virus (AAV)
-
Adenovirus
Master and Working Viral Banks
Pure viral seeds, more than starting materials used to create viral banks, they serve as the foundation for assessing the lifetime quality of your biopharmaceutical. We offer full service solutions from master viral bank creation to drug product lot release including complete characterization of genetic and phenotypic stability.
Oncolytic Viruses
An emerging “dual threat” in the fight against cancer, oncolytic viruses are utilized as either a monotherapy or combined with existing checkpoint inhibitors/T cell therapies to provide an enhanced therapeutic response. Since 2015, we have committed significant financial resources to create the necessary manufacturing and testing infrastructure needed to facilitate rapid development.
Oncolytic Viruses
An emerging “dual threat” in the fight against cancer, oncolytic viruses are utilized as either a monotherapy or combined with existing checkpoint inhibitors/T cell therapies to provide an enhanced therapeutic response. Since 2015, we have committed significant financial resources to create the necessary manufacturing and testing infrastructure needed to facilitate rapid development.
